OncoSec Medical Correlations
| ONCSDelisted Stock | USD 0.06 0 3.63% |
The current 90-days correlation between OncoSec Medical and ZyVersa Therapeutics is 0.11 (i.e., Average diversification). The correlation of OncoSec Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
OncoSec Medical Correlation With Market
Significant diversification
The correlation between OncoSec Medical and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding OncoSec Medical and DJI in the same portfolio, assuming nothing else is changed.
OncoSec |
Moving together with OncoSec Stock
| 0.82 | EPGG | Empire Global Gaming | PairCorr |
| 0.64 | TPDDF | Talon Energy | PairCorr |
| 0.68 | IMHC | Imperalis Holding Corp | PairCorr |
| 0.87 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.81 | DD | Dupont De Nemours Fiscal Year End 4th of February 2025 | PairCorr |
| 0.62 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.8 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.89 | KO | Coca Cola Fiscal Year End 11th of February 2025 | PairCorr |
Moving against OncoSec Stock
| 0.86 | T | ATT Inc Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.85 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.83 | BLK | BlackRock Fiscal Year End 10th of January 2025 | PairCorr |
| 0.79 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.62 | MSFT | Microsoft | PairCorr |
| 0.54 | TSM | Taiwan Semiconductor Fiscal Year End 16th of January 2025 | PairCorr |
| 0.5 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
| 0.33 | GSTX | Graphene Solar Techn | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between OncoSec Stock performing well and OncoSec Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze OncoSec Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ZVSA | 4.00 | (0.88) | 0.00 | (0.20) | 0.00 | 10.00 | 78.93 | |||
| PALI | 5.36 | (0.60) | 0.00 | (3.25) | 0.00 | 5.97 | 93.57 | |||
| UNCY | 4.28 | 1.19 | 0.21 | (3.29) | 3.96 | 14.00 | 29.22 | |||
| APGN | 5.12 | 0.09 | 0.01 | (3.34) | 5.50 | 7.89 | 58.79 | |||
| IMMX | 5.34 | 0.83 | 0.14 | (1.25) | 5.14 | 17.36 | 35.42 | |||
| PHIO | 5.37 | (0.70) | 0.00 | (2.79) | 0.00 | 9.81 | 48.43 | |||
| ATNF | 13.27 | 3.40 | 0.39 | 1.21 | 7.66 | 16.10 | 358.73 | |||
| NAVB | 6.04 | (1.10) | 0.00 | 0.54 | 0.00 | 12.50 | 40.40 | |||
| FWBI | 5.73 | (1.81) | 0.00 | (2.95) | 0.00 | 8.65 | 65.42 |
View OncoSec Medical Related Equities
| Risk & Return | Correlation |
OncoSec Medical Corporate Management
| Robert CPA | VP Controller | Profile | |
| Kim Jaffe | Assistant Operations | Profile | |
| Robert Arch | CEO Pres | Profile | |
| Tu MSc | VP Operations | Profile | |
| CPA CFA | Exec CFO | Profile | |
| Mai MD | Consultant | Profile | |
| Sandra Aung | Sr Officer | Profile |
Still Interested in OncoSec Medical?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.